Verkkokauppa.com Oyj
14.11.2025 18:00:00 CET | Globenewswire | Press release
Verkkokauppa.com Oyj: Acquisition of own shares on 14 November 2025
Verkkokauppa.com Oyj: Acquisition of own shares on 14 November 2025
Verkkokauppa.com Oyj, Stock Exchange Release, 14 November 2025 at 07:00 p.m. EET
Verkkokauppa.com Oyj: Acquisition of own shares on 14 November 2025
| Date | 14 November 2025 | |
| Exchange transaction | Buy | |
| Share trading code | VERK | |
| Amount, shares | 16,740 | |
| Average price/share (EUR) | 3.9348 | |
| Total cost (EUR) | 65,868.55 |
After the acquisitions Verkkokauppa.com Oyj holds a total of 265,476 treasury shares.
On behalf of Verkkokauppa.com Oyj
Danske Bank A/S, Finland Branch
Antti Väliaho Jonathan Nyberg
For more information, please contact:
Jesper Blomster, CFO
Verkkokauppa.com Oyj
jesper.blomster@verkkokauppa.com
Verkkokauppa.com is an e-commerce pioneer that stands passionately on the customer’s side. Verkkokauppa.com accelerates the transition of commerce to online with Finland’s fastest deliveries and ultimate convenience. The company leads the way by offering one-hour deliveries to more than 1.7 million customers, a winning assortment and probably always cheaper prices. Every day, the company strives to find more streamlined ways to surpass its customers' expectations and to create a new norm for buying and owning.
Verkkokauppa.com was founded in 1992 and has been online since day one. The company’s revenue in 2024 was EUR 468 million and it employs around 600 people. Verkkokauppa.com is listed on the Nasdaq Helsinki stock exchange.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom